Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT02138812
Status:
TERMINATED
Last Update Posted:
2018-10-12
First Post:
2014-05-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-02
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-08
First Submit QC Date:
None
Study First Post Date:
2014-05-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-10
Last Update Post Date:
2018-10-12
Last Update Post Date Type:
ACTUAL